原本
IN MY OPINION --- In my midwest location, I'm unaware of any research or clinical trials available to GBS patients. GBS is rare, & not a serious enough problem in scale to command the widespread attention of the public, compared to cancer, heart disease, or diabetes. Big PHARMA puts it's research investments where it will produce the greatest returns. Realistically, we're fortunate that we know as much as we do know about GBS (which is that GBS is not one single disease, but a variety of acute neuropathies with a number of related immune system behaviors). I'd remain aware of the latest published literature, books on GBS, books on neuropathy, to try to understand the latest strategies for coping with GBS.